It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition ...

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

A new Australian study has found that a simple saline nasal spray could help many children breathe and sleep better, ...

Randomized trial shows resolution of about half of cases, on par with intranasal steroids ...

KBIA’s Rebecca Smith recently sat down with Dr. Mohammad Badran at the University of Missouri who studies sleep apnea to ...

Obese patients with type 2 diabetes are less likely to need a CPAP machine to treat sleep apnea if they’re taking a GLP-1 drug, researchers recently reported in JAMA Network Open. Patients were also ...

Learn the hidden signs of sleep apnea, its impact on health, and how effective treatment can restore your energy and improve ...

Biotech firm Apnimed plans to seek FDA approval for its sleep apnea drug, with market availability expected by 2027 ...

TORONTO, ONTARIO, CANADA - 2014/04/12: Female wearing the CPAP mask for treating the sleep apnea which is a type of sleep disorder characterized by pauses in breathing or instances of shallow or ...

Investing.com -- Inspire Medical Systems (NYSE:INSP) stock fell 12.6% Thursday after the Centers for Medicare & Medicaid ...

The sleep apnea devices market is primarily driven by the rising prevalence of obstructive sleep apnea (OSA) and related risk factors, as well as by growing public health initiatives, awareness ...